When:
Monday, Apr 23, 2018 8:00a -
Wednesday, Apr 25, 2018 6:00p

Where:
Revere Hotel Boston Common
200 Stuart Stree
Boston, MA 02116

Admission:
$699

Categories:
Lectures & Conferences

Event website:
http://go.evvnt.com/169819-0

As the industry's most comprehensive NASH forum, the NASH Summit returns with an unrivalled depth and breadth of cutting-edge NASH science from drug discovery through to late stage clinical development.

Across 3 parallel streams of learning, 48 expert speakers including Gilead, Allergan and Novartis will share advances in:

• Validating non-invasive biomarkers to confidently stratify patients and enhance clinical response
• Evaluating the scientific rationale behind combination therapy for more effective treatment
• Conclusively comparing in vitro and in vivo models to better recapitulate human NASH and confidently progress into the clinic

Join 150+ drug developers from 120+ organizations at this focused discussion and networking forum. Address this huge unmet clinical need and gain actionable insights to propel your candidate to therapeutic success.

Urls:

Brochure: https://go.evvnt.com/169819-1
Booking: https://go.evvnt.com/169819-2

Price
Conference Only: USD 2599
Workshop Only: USD 699

Speakers: Jason Campagna (Intercept Pharmaceuticals), Philip Just Larsen (Sanofi), Jamie Bates (Gilead Sciences), Dean Hurn (Genfit), Edgar Charles (Bristol-Myers Squibb)

Share this event

Add to:

23/04/2018 08:00:00 25/04/2018 18:00:00 15 2nd Annual NASH Summit 2018 As the industry's most comprehensive NASH forum, the NASH Summit returns with an unrivalled depth and breadth of cutting-edge NASH science from drug discovery through to late stage clinical develop... Revere Hotel Boston Common, Boston, MA 02116 Organizer Organizer e-mail false DD/MM/YYYY Reddit